130539-43-4

Basic information

• Product Name: Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside
• Synonyms: Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside;Ethyl 2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside
• CAS NO: 130539-43-4
• Molecular Formula: C₁₆H₁₉NO₆S
• Molecular Weight: 353.39016
• Mol File: 130539-43-4.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 594.3±50.0 °C(Predicted)
• Appearance: /
• Density: 1.52±0.1 g/cm3(Predicted)
• PKA: 13.00±0.70(Predicted)
• CAS DataBase Reference: Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside(130539-43-4)
• EPA Substance Registry System: Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside(130539-43-4)

Safety Data

• Hazardous Substances Data: 130539-43-4(Hazardous Substances Data)

Usage

General Description

Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside is a chemical compound that is used in the field of organic chemistry and medicinal chemistry. It is a derivative of beta-D-glucopyranoside and contains a thiol group, a thio-beta-D-glucopyranoside moiety, and a unique 2H-isoindol-2-yl ring structure. Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside may have potential applications in drug discovery and development due to its unique structural features and potential biological activities. Further research and studies are needed to explore the potential uses and effects of this chemical compound.

Upstream product

• 99409-32-2 ethyl-3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 10022-13-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-D-glucopyranose 
• 10022-13-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
• 31505-46-1 tetra-O-acetyl-2-(2-carboxy-benzoylamino)-2-deoxy-β-D-glucopyranose 
• 85-44-9 phthalic anhydride 
• 17460-45-6 tetra-acetyl glucosamine 
• 90-76-6 2-deoxy-2-amino glucose 
• 31505-45-0 2-deoxy-2-phthalimido-D-glucopyranose 
• 31505-42-7 2-(2-carboxybenzamido)-2-deoxy-D-glucopyranose 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 72858-55-0 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-D-glucopyranose 

Downstream Products

• 129519-28-4 2-((6S,7R,8aS)-6-ethylsulfanyl-8-hydroxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl)-isoindole-1,3-dione 
• 130539-46-7 ethyl 3,6-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 168644-99-3 ethyl 3,4,6-tri-O-benzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 215439-81-9 ethyl 6-O-tert-butyldiphenylsilyl-2-deoxy-2-phthalimido-1-thio-β-glucopyranoside 
• 210472-31-4 ethyl 3,4-di-O-acetyl-2-deoxy-2-phthalimido-6-O-p-toluenesulfonyl-1-thio-β-D-glucopyranoside 
• 99409-33-3 ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside 
• 932015-07-1 ethyl 6-O-(3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 933790-98-8 6-O-(3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl bromide 
• 933790-88-6 ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-6-O-trityl-β-D-glucopyranoside 
• 919078-09-4 ethyl 3-O-acetyl-6-O-benzyl-2-deoxy-2-phthalimido-4-O-(trifluoromethylsulfonyl)-1-thio-β-D-glucopyranoside 
• 125520-04-9 ethyl 3-O-acetyl-4,6-O-benzylidene-1,2-deoxy-2-N-phthalimido-1-thio-β-D-glucopyranoside 
• 263358-64-1 ethyl 3-O-acetyl-6-O-benzyl-1,2-deoxy-2-N-phthalimido-1-thio-β-D-glucopyranoside 
• 866885-62-3 ethyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1->4)-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 866885-61-2 ethyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1->4)-6-O-tert-butyldimethylsilyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 

Relevant articles and documents

ANTIMICROBIAL VACCINE COMPOSITIONS

This invention is directed to antimicrobial vaccine compounds and compositions comprising oligosaccharide β-(1→6)- glucosamine groups having from 3 to 12 glucosamine units linked through a linker group to tetanus toxoid wherein the toxoid is primarily in

METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG COMPRISING MICROBES

Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups.

Ionic-liquid supported rapid synthesis of an: N -glycan core pentasaccharide on a 10 g scale

A new and efficient Ionic Liquid-Supported Oligosaccharide Synthesis (ILSOS) strategy for an N-linked core pentasaccharide on a 10 g scale is reported. This new ILSOS includes a new spacer for an IL support, a new tagging strategy, and fast, efficient and orthogonal removal of the ionic-liquid support, producing the N-linked core pentasaccharide with direct applicability potential in a short time, with high yield and on a large gram scale.